CytomX Therapeutics Inc
NASDAQ:CTMX

Watchlist Manager
CytomX Therapeutics Inc Logo
CytomX Therapeutics Inc
NASDAQ:CTMX
Watchlist
Price: 1 USD -0.99% Market Closed
Market Cap: 78.1m USD
Have any thoughts about
CytomX Therapeutics Inc?
Write Note

CytomX Therapeutics Inc
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

CytomX Therapeutics Inc
Cash Equivalents Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
CytomX Therapeutics Inc
NASDAQ:CTMX
Cash Equivalents
$40.6m
CAGR 3-Years
-44%
CAGR 5-Years
-24%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash Equivalents
$7.3B
CAGR 3-Years
-16%
CAGR 5-Years
-7%
CAGR 10-Years
-1%
Gilead Sciences Inc
NASDAQ:GILD
Cash Equivalents
$5B
CAGR 3-Years
5%
CAGR 5-Years
-12%
CAGR 10-Years
-2%
Amgen Inc
NASDAQ:AMGN
Cash Equivalents
$9B
CAGR 3-Years
-9%
CAGR 5-Years
-5%
CAGR 10-Years
9%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash Equivalents
$6.5B
CAGR 3-Years
1%
CAGR 5-Years
14%
CAGR 10-Years
25%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash Equivalents
$2B
CAGR 3-Years
-16%
CAGR 5-Years
8%
CAGR 10-Years
12%

See Also

What is CytomX Therapeutics Inc's Cash Equivalents?
Cash Equivalents
40.6m USD

Based on the financial report for Sep 30, 2024, CytomX Therapeutics Inc's Cash Equivalents amounts to 40.6m USD.

What is CytomX Therapeutics Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
-24%

Over the last year, the Cash Equivalents growth was 56%. The average annual Cash Equivalents growth rates for CytomX Therapeutics Inc have been -44% over the past three years , -24% over the past five years .

Back to Top